@article{af87954260a94f44b5e3b73ce37087e8,
title = "Trends in Lower Limb Revascularization Among Patients With End-Stage Renal Failure: Where Is the Journey Going, and How Far Have We Come?∗",
keywords = "end-stage renal failure, endovascular, lower limb, surgery",
author = "Eckstein, {Hans Henning} and Claudius Kuechle and Stadlbauer, {Thomas Hans Werner}",
note = "Funding Information: Dr. Eckstein has received research funding from Bayer. Dr. Stadlbauer is a speaker for Bayer, Bristol-Myers Squibb, Pfizer, and Daiichi Sankyo. Dr. Kuchle has reported that he has no relationships relevant to the contents of this paper to disclose. ",
year = "2017",
month = oct,
day = "23",
doi = "10.1016/j.jcin.2017.06.061",
language = "English",
volume = "10",
pages = "2111--2112",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "20",
}